-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Introduction: Malay acidfor maintenance therapy in adult patients with chronic obstructive pulmonary disease (COPD).
August 12, Health Meta Pharmaceutical Group Co., Ltd. announced that it had received a notice of approval for clinical trials of Malay aciddatero inhalation powder mist from the State Drug Administration.
malay acidinhalation powder mist for health yuan independent research and development products.
the active ingredient in this product Datro is a bronchial esotherapy agent, belonging to a new generation of long-acting inhaled beta2-subjected astration agent, mainly used in the maintenance treatment of adult patients with chronic obstructive pulmonary disease (COPD).
the original product was Malay aciddatero inhalation powder mist (commodity name: Anrun ®), which was approved by the State Drug Administration in June 2012 for domestic listing.
, there are no imitation products on the market.
, a total of 2 enterprises in China have declared (including health yuan).
.